We are live on ! Find out more
ICCM icon

IceCure Medical

17 hedge funds and large institutions have $247K invested in IceCure Medical in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

61% more capital invested

Capital invested by funds: $154K → $247K (+$93.2K)

31% more funds holding

Funds holding: 1317 (+4)

0.01% more ownership

Funds ownership: 0.01%0.01% (+0.01%)

Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ICCM Hedge Fund Activity: Q2 2025 in Review

17 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2025, worth a combined $247K — up 61% from $154K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ICCM positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $56.3K. The largest seller was XTX Topco, exiting entirely with an estimated $26K sold.

  • 17 institutional investors held IceCure Medical (ICCM) as of Q2 2025, up from 13 in Q1 2025.
  • Funds reported $247K of IceCure Medical stock for Q2 2025, up 61% quarter-over-quarter.
  • 6 funds opened new IceCure Medical positions in Q2 2025 and 2 closed out, a net change of +4 holders.
  • The largest IceCure Medical buyer in Q2 2025 was Citadel Advisors, an estimated $56.3K added.
  • The largest IceCure Medical seller in Q2 2025 was XTX Topco, an estimated $26K sold.

Based on aggregated 13F filings for Q2 2025.